Central Ohio Transit Authority abandons B10 blend, citing biodiesel costs

In Ohio, the Central Ohio Transit Authority has discontinued a two-year program of blending biodiesel, due to high prices. COTA executives said that a two-year agreement for biodiesel at $2.40 per gallon has expired and the organization is facing new spot prices of $4.44 per gallons, and said that COTA was better off using conventional diesel at $3.81 per gallon and using the difference to put more buses on the street. COTA said that it would carry 22 passengers per hour, and the resulting increase in bus service would take vehicles off the road.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Toledo Regional Transit converts 25 percent of fleet to B20 biodiesel

In Ohio, the Toledo Area Regional Transit Authority converted 10 buses to B20 biodiesel to coincide with Earth Day festivities. 25 percent of TARTA's fleet now runs on biodiesel blends....

Greenville, South Carolina converts transit fleet to biodiesel

In South Carolina, the Greenville Transit Authority was renamed Greenlink and has converted its fleet to an undisclosed biodiesel blend....

Ohio Air Quality Development Authority approves $55 million bond issue for 110 Mgy ethanol plant

In Ohio, the Ohio Air Quality Development Authority has approved issue of $55 million in bonds to assist in financing a 110 Mgy Darke County ethanol plant that will be operated by The Andersons (ANDE)...

Canadian city converts public transit to B5 biodiesel

Kelowna Regional Transit System has switched its 64 buses to a B5 biodiesel blend. The British Columbia government announced earlier this year it would reduce greenhouse gas emissions 33 per cent by 2...

Michigan’s Traverse City school district abandons biodiesel over cost, slude concerns

In Michigan, the Traverse City School District has abandoned a five-year biodiesel program, citing cost concerns as well as a build-up of sludge in its school bus tank storage system that it said will...

Biofuel catalyst maker Codexis abandons $100 million IPO, citing market conditions

In New York, biocatalyst developer Codexis, which numbers Chevron, Bio*One Capital and Pfizer among its investors, cancelled a $100 million IPO, citing "unfavorable market conditions". The company man...